Emerald Mutual Fund Advisers Trust’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-753,981
Closed -$9.03M 226
2022
Q3
$9.03M Sell
753,981
-907,499
-55% -$11.3M 0.57% 71
2022
Q2
$13.9M Hold
1,661,480
0.81% 47
2022
Q1
$14.4M Sell
1,661,480
-143,825
-8% -$1.39M 0.64% 62
2021
Q4
$20.4M Buy
1,805,305
+227,558
+14% +$2.7M 0.72% 54
2021
Q3
$19.8M Buy
1,577,747
+316,667
+25% +$2.92M 0.69% 56
2021
Q2
$10.2M Buy
1,261,080
+812,728
+181% +$7.05M 0.34% 103
2021
Q1
$4.15M Buy
+448,352
New +$4.52M 0.14% 138

Other funds holding GOSS

Emerald Mutual Fund Advisers Trust's GOSS Position: Q4 2022 in Review

Emerald Mutual Fund Advisers Trust sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 753,981 shares — an estimated $9.03M sold.

Emerald Mutual Fund Advisers Trust first reported a position in GOSS in Q1 2021 and held it in 7 quarters. The position peaked at $20.4M in Q4 2021. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Emerald Mutual Fund Advisers Trust reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 753,981 Gossamer Bio shares in Q4 2022, an estimated $9.03M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Gossamer Bio in Q1 2021 and held it in 7 quarters.
  • Emerald Mutual Fund Advisers Trust's Gossamer Bio position peaked at $20.4M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2022, filed 3 Feb 2023.